Geographically North America dominated stem cell therapies market driven by best in class infrastructure, best in industry practices and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for stem cell therapies market. Asia Pacific is projected to have fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, increased spending, and increasing awareness amongst population in developing nations such as China, and India in this region.
This report identifies the global stem cell therapies market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global stem cell therapies market.
This report segments global stem cell therapies market on the basis of therapies, applications and regional market as follows:
Stem Cell Therapies Market research report is classified on the basis of therapies. Some of the major therapies covered in this report are as follows: Allogeneic Stem Cell Therapy Market, By Application (Eye Diseases, GIT Diseases, Immune System Diseases, Metabolic Diseases, Musculoskeletal Disorders, CNS Diseases, CVS Diseases, Wounds and Injuries and Other Diseases) Autologous Stem Cell Therapy Market, By Application (GIT Diseases, CNS Diseases, Musculoskeletal Disorders, Wounds and Injuries, CVS Diseases and Other Diseases)
Stem Cell Therapies Market research report is classified on the basis of applications. Some of the major applications covered in this report are as follows: Eye Diseases, GIT Diseases, Immune System Diseases, Metabolic Diseases, Musculoskeletal Disorders, CNS Diseases, CVS Diseases, Wounds and Injuries and Other Diseases
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the stem cell therapies market. Some of the major companies’ profiles in detail are as follows:
Advanced Cell Technologies, Inc.
Cellular Dynamics International
Cytori Therapeutics, Inc.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Stem Cell Therapies Market– Market Forces
4.1.1. Development of Advanced Genomic Methods for Stem Cell Analysis
4.1.2. Increasing Focus on Human Embryonic Stem Cells
4.2.1. Difficulties Related With The Preservation of Stem Cells
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Stem Cell Therapies Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Stem Cell Therapies Market, By Therapy
6.1. Allogeneic Stem Cell Therapy Market, By Application
6.1.1. Eye Diseases
6.1.2. GIT Diseases
6.1.3. Immune System Diseases
6.1.4. Metabolic Diseases
6.1.5. Musculoskeletal Disorders
6.1.6. CNS Diseases
6.1.7. CVS Diseases
6.1.8. Wounds and Injuries
6.1.9. Other Diseases
6.2. Autologous Stem Cell Therapy Market, By Application
6.2.1. GIT Diseases
6.2.2. CNS Diseases
6.2.3. Musculoskeletal Disorders
6.2.4. Wounds and Injuries
6.2.5. CVS Diseases
6.2.6. Other Diseases
7. Stem Cell Therapies Market, By Applications
7.1. Eye Diseases
7.2. GIT Diseases
7.3. Immune System Diseases
7.4. Metabolic Diseases
7.5. Musculoskeletal Disorders
7.6. CNS Diseases
7.7. CVS Diseases
7.8. Wounds and Injuries
7.9. Other Diseases
8. Stem Cell Therapies Market, By Geography
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.4. Rest of the World (RoW)
8.4.2. Rest of RoW
9. Stem Cell Therapies Market – Market Entropy
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. Advanced Cell Technologies, Inc.
10.2. Athersys Inc.
10.3. Celgene Corporation
10.4. Cellular Dynamics International
10.5. Cytori Therapeutics, Inc.
10.6. Fibrocell Science, Inc.
10.7. Gamida Cell Ltd.
10.8. Mesoblast Ltd.
10.9. Pluristem Therapeutics Inc.
10.10. Stemcells Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights